0000899243-20-019856.txt : 20200721 0000899243-20-019856.hdr.sgml : 20200721 20200721192943 ACCESSION NUMBER: 0000899243-20-019856 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200717 FILED AS OF DATE: 20200721 DATE AS OF CHANGE: 20200721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frail Donald CENTRAL INDEX KEY: 0001817514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39381 FILM NUMBER: 201039929 MAIL ADDRESS: STREET 1: C/O PANDION THERAPEUTICS, INC. STREET 2: 134 COOLIDGE AVE., 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pandion Therapeutics, Inc. CENTRAL INDEX KEY: 0001807901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833015614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-393-5925 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Pandion Therapeutics Holdco LLC DATE OF NAME CHANGE: 20200327 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-17 0 0001807901 Pandion Therapeutics, Inc. PAND 0001817514 Frail Donald C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE WATERTOWN MA 02472 1 0 0 0 Common Stock 2020-07-21 4 C 0 11741 A 51113 D Common Stock 2020-07-21 4 P 0 10000 18.00 A 61113 D Stock Option (right to buy) 18.00 2020-07-17 4 A 0 4750 0.00 A 2030-07-16 Common Stock 4750 4750 D Stock Option (right to buy) 18.00 2020-07-17 4 A 0 13997 0.00 A 2030-07-16 Common Stock 13997 13997 D Series B Preferred Stock 2020-07-21 4 C 0 59872 0.00 D Common Stock 11741 0 D The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share. This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on September 27, 2020, with the remainder of the shares vesting in equal monthly installments following September 27, 2020 through September 27, 2023, subject to the reporting person's continued service on each applicable vesting date. This option award was granted on July 17, 2020. The shares underlying the award vest in equal monthly installments following July 17, 2020 through July 17, 2023, subject to the reporting person's continued service on each applicable vesting date. /s/ Edward Freedman, as attorney-in-fact for Donald E. Frail 2020-07-21